Literature DB >> 14508193

Soluble CD14 and aortic stiffness in a population-based study.

Jacques Amar1, Jean B Ruidavets, Claire Bal Dit Sollier, Vanina Bongard, Henri Boccalon, Bernard Chamontin, Ludovic Drouet, Jean Ferrières.   

Abstract

OBJECTIVE: Soluble CD14 (sCD14), an effective mediator for the activation of monocytes by bacterial endotoxin is involved in the release of substances able to modify the characteristics of the arterial wall. The aim of this study was to investigate, in humans, the relationship of sCD14 with aortic stiffness and to analyse the influence of arterial structure and endothelial function on this relationship.
DESIGN: Cross-sectional population-based study. PARTICIPANTS: One thousand and fifteen subjects randomly selected from the polling lists, were recruited by the Toulouse MONICA centre between 1995 and 1997.
METHODS: Carotid-femoral pulse wave velocity (PWV) and blood pressure (BP) were measured in the supine position. Common carotid intima-media thickness (IMT) and the presence of plaques were assessed by ultrasonography. sCD14 was measured using an immunoenzymatic method.
RESULTS: The results concern the 891 subjects with complete data for all the variables. In the bivariate analyses, PWV (P < 0.001), systolic BP (P < 0.05), pulse pressure (PP) (P < 0.01), IMT (P < 0.001), the number of plaques (P < 0.05) and von Willebrand factor activity (vWFa) (P < 0.001) were positively associated with sCD14, whereas no significant relationship was observed between sCD14 and diastolic BP. After adjustment for age and sex, no significant relationship remained between IMT, the number of plaques, SBP, PP and sCD14. A significant and positive relationship was observed between sCD14 and PWV (trend P < 0.05) after adjustment for numerous confounders.
CONCLUSION: This population-based study yields first evidence that sCD14 is associated with aortic stiffness independently of age, BP and atherosclerosis in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508193     DOI: 10.1097/00004872-200310000-00014

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  20 in total

1.  Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Tatsuya Shoji; Yoshitsugu Obi; Tomoko Namba; Harumi Kitamura; Tetsuya Kaneko; Noriyuki Okada; Hirotsugu Iwatani; Atsushi Yamauchi; Yoshiharu Tsubakihara; Enyu Imai; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

2.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

Review 3.  Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.

Authors:  Sasha A Fahme; Gerald S Bloomfield; Robert Peck
Journal:  Hypertension       Date:  2018-05-18       Impact factor: 10.190

4.  Marital distress, depression, and a leaky gut: Translocation of bacterial endotoxin as a pathway to inflammation.

Authors:  Janice K Kiecolt-Glaser; Stephanie J Wilson; Michael L Bailey; Rebecca Andridge; Juan Peng; Lisa M Jaremka; Christopher P Fagundes; William B Malarkey; Bryon Laskowski; Martha A Belury
Journal:  Psychoneuroendocrinology       Date:  2018-08-04       Impact factor: 4.905

5.  Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults.

Authors:  Alex P Reiner; Ethan M Lange; Nancy S Jenny; Paulo H M Chaves; Jaclyn Ellis; Jin Li; Jeremy Walston; Leslie A Lange; Mary Cushman; Russell P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

6.  Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier Donate-Correa; Violeta Cazaña-Pérez; Javier García-Pérez
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

Review 7.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

8.  Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

Authors:  Dominic S C Raj; Juan J Carrero; Vallabh O Shah; Abdul R Qureshi; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Jennet Ferguson; Pope L Moseley; Peter Stenvinkel
Journal:  Am J Kidney Dis       Date:  2009-09-06       Impact factor: 8.860

9.  The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes.

Authors:  Cassie M Mitchell; Brenda M Davy; Tanya M Halliday; Mathew W Hulver; Andrew P Neilson; Monica A Ponder; Kevin P Davy
Journal:  Contemp Clin Trials       Date:  2015-10-28       Impact factor: 2.226

10.  Soluble CD14 and Risk of Heart Failure and Its Subtypes in Older Adults.

Authors:  Sadeer G Al-Kindi; Petra Buzkova; Sanyog G Shitole; Alex P Reiner; Parveen K Garg; John S Gottdiener; Bruce M Psaty; Jorge R Kizer
Journal:  J Card Fail       Date:  2020-03-09       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.